CN Stock MarketDetailed Quotes

Shandong Boyuan Pharmaceutical&Chemical (301617)

Watchlist

61.37
+3.51+6.07%

Market Closed Apr 17 15:00 CST

8.20BMarket Cap46.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shandong Boyuan Pharmaceutical&Chemical (301617) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

6.60%1.07B

7.39%746.79M

4.02%320.24M

29.53%1.33B

34.91%1.01B

33.98%695.4M

307.87M

28.39%1.03B

23.55%746.43M

34.18%519.04M

Operating revenue

6.60%1.07B

7.39%746.79M

4.02%320.24M

29.53%1.33B

34.91%1.01B

33.98%695.4M

--307.87M

28.39%1.03B

23.55%746.43M

34.18%519.04M

Other operating revenue

----

3,381.67%22.25M

----

-45.31%2.01M

----

-70.56%639.08K

----

102.63%3.68M

--2.69M

186.74%2.17M

Total operating cost

13.67%927.21M

14.35%634.75M

6.79%265.34M

33.28%1.09B

42.26%815.68M

42.58%555.09M

248.48M

38.74%816.61M

573.36M

50.75%389.32M

Operating cost

12.74%845.09M

14.61%585.5M

4.18%240.53M

35.12%998.8M

44.64%749.59M

44.91%510.86M

--230.87M

42.81%739.2M

--518.23M

58.11%352.54M

Operating tax surcharges

-24.75%4.13M

-33.78%2.93M

-28.64%1.24M

32.19%6.9M

30.12%5.48M

39.49%4.43M

--1.74M

45.20%5.22M

--4.22M

13.43%3.17M

Operating expense

4.20%8.3M

-2.69%5.21M

-9.07%2.63M

34.20%11.67M

31.15%7.96M

52.30%5.36M

--2.89M

61.93%8.7M

--6.07M

58.75%3.52M

Administration expense

17.69%25.01M

14.55%15.66M

15.25%7.56M

9.37%31.46M

1.85%21.25M

-0.37%13.67M

--6.56M

-8.61%28.77M

--20.86M

-9.10%13.72M

Financial expense

98.13%-21.01K

98.11%-13.84K

65.06%-269.19K

-90.42%-1.81M

-52.47%-1.12M

-74.00%-732.68K

---770.53K

-2,618.65%-948.82K

---735.43K

-1,476.41%-421.08K

-Interest expense (Financial expense)

-76.08%49.42K

-66.36%46.19K

-37.42%42.96K

16,286.85%25.26K

133,928.10%206.62K

88,955.87%137.29K

--68.64K

-99.97%154.16

--154.16

-98.19%154.16

-Interest Income (Financial expense)

39.80%-1.41M

24.20%-1.21M

-30.17%-937.87K

-184.60%-3.24M

-204.39%-2.34M

-352.60%-1.59M

---720.48K

-124.87%-1.14M

---769.68K

-226.55%-352.06K

Research and development

37.48%44.7M

18.35%25.46M

89.99%13.66M

15.90%41.34M

31.53%32.52M

28.12%21.51M

--7.19M

17.00%35.67M

--24.72M

10.89%16.79M

Credit Impairment Loss

-370.20%-1.12M

-842.04%-972.36K

-516.84%-843.02K

103.42%128.81K

93.70%-237.76K

102.86%131.04K

--202.24K

-1,822.97%-3.77M

---3.77M

-71.24%-4.59M

Asset Impairment Loss

-18.76%-188.99K

33.23%-158.02K

----

-26.82%-244.84K

94.42%-159.14K

80.48%-236.67K

---571.76K

93.95%-193.06K

---2.85M

-311.46%-1.21M

Other net revenue

92.41%7.66M

6,142.01%3.11M

279.02%560.2K

2,090.01%5.24M

150.68%3.98M

99.25%-51.48K

-312.93K

93.60%-263.52K

-7.85M

-113.59%-6.86M

Invest income

181.90%3.23M

126.97%802.06K

77.71%-334.9K

-98.28%-4.58M

-137.15%-3.94M

-98.57%-2.97M

---1.5M

-24.49%-2.31M

---1.66M

-142.65%-1.5M

Asset deal income

451.86%96.07K

793.83%96.07K

365.16%50K

---25.59K

---27.3K

--10.75K

----

Other revenue

-32.44%5.64M

10.79%3.34M

9.03%1.69M

65.92%9.96M

1,818.69%8.35M

593.56%3.02M

--1.55M

1,545.52%6M

--435K

Operating profit

-21.19%153.92M

-17.91%115.14M

-6.13%55.45M

17.51%244.75M

18.22%195.31M

14.16%140.26M

59.08M

1.21%208.28M

-7.95%165.22M

-1.99%122.86M

Add:Non operating Income

2,755.13%6.85K

2,533.17%6.32K

--16.57K

-99.42%922.25

-99.85%240.08

-99.04%240

----

407.21%159.42K

--159.42K

25.65%25K

Less:Non operating expense

26,811.36%2.69M

26,211.40%2.63M

--2.01

-80.28%110K

-97.98%10K

----

-87.61%557.8K

--494.48K

83.30%494.48K

Total profit

-22.56%151.23M

-19.77%112.52M

-6.10%55.47M

17.68%244.64M

18.45%195.3M

14.59%140.25M

59.08M

3.26%207.88M

-7.68%164.88M

-2.17%122.39M

Less:Income tax cost

-23.62%18.77M

-25.19%13.48M

-19.37%6.39M

22.26%31.52M

15.37%24.58M

10.97%18.01M

--7.93M

3.17%25.78M

--21.31M

-1.65%16.23M

Net profit

-22.41%132.46M

-18.97%99.04M

-4.05%49.08M

17.04%213.13M

18.91%170.72M

15.14%122.23M

51.15M

3.28%182.1M

-7.58%143.58M

-2.24%106.16M

Net profit from continuing operation

-22.41%132.46M

-18.97%99.04M

-4.05%49.08M

17.04%213.13M

18.91%170.72M

15.14%122.23M

--51.15M

3.28%182.1M

--143.58M

-2.24%106.16M

Net profit of parent company owners

-22.41%132.46M

-18.97%99.04M

-4.05%49.08M

17.04%213.13M

18.91%170.72M

15.14%122.23M

--51.15M

3.28%182.1M

-7.58%143.58M

-2.24%106.16M

Earning per share

Basic earning per share

-55.24%0.9912

-53.25%0.7411

-28.04%0.4774

16.95%2.76

19.05%2.2143

14.88%1.5854

--0.6634

3.06%2.36

--1.86

-2.13%1.38

Diluted earning per share

-55.24%0.9912

-53.25%0.7411

-28.04%0.4774

16.95%2.76

19.05%2.2143

14.88%1.5854

--0.6634

3.06%2.36

--1.86

-2.13%1.38

Other composite income

Total composite income

-22.41%132.46M

-18.97%99.04M

-4.05%49.08M

17.04%213.13M

18.91%170.72M

15.14%122.23M

51.15M

3.28%182.1M

143.58M

-2.24%106.16M

Total composite income of parent company owners

-22.41%132.46M

-18.97%99.04M

-4.05%49.08M

17.04%213.13M

18.91%170.72M

--122.23M

--51.15M

--182.1M

--143.58M

----

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	6.60%1.07B	7.39%746.79M	4.02%320.24M	29.53%1.33B	34.91%1.01B	33.98%695.4M	307.87M	28.39%1.03B	23.55%746.43M	34.18%519.04M
Operating revenue	6.60%1.07B	7.39%746.79M	4.02%320.24M	29.53%1.33B	34.91%1.01B	33.98%695.4M	--307.87M	28.39%1.03B	23.55%746.43M	34.18%519.04M
Other operating revenue	----	3,381.67%22.25M	----	-45.31%2.01M	----	-70.56%639.08K	----	102.63%3.68M	--2.69M	186.74%2.17M
Total operating cost	13.67%927.21M	14.35%634.75M	6.79%265.34M	33.28%1.09B	42.26%815.68M	42.58%555.09M	248.48M	38.74%816.61M	573.36M	50.75%389.32M
Operating cost	12.74%845.09M	14.61%585.5M	4.18%240.53M	35.12%998.8M	44.64%749.59M	44.91%510.86M	--230.87M	42.81%739.2M	--518.23M	58.11%352.54M
Operating tax surcharges	-24.75%4.13M	-33.78%2.93M	-28.64%1.24M	32.19%6.9M	30.12%5.48M	39.49%4.43M	--1.74M	45.20%5.22M	--4.22M	13.43%3.17M
Operating expense	4.20%8.3M	-2.69%5.21M	-9.07%2.63M	34.20%11.67M	31.15%7.96M	52.30%5.36M	--2.89M	61.93%8.7M	--6.07M	58.75%3.52M
Administration expense	17.69%25.01M	14.55%15.66M	15.25%7.56M	9.37%31.46M	1.85%21.25M	-0.37%13.67M	--6.56M	-8.61%28.77M	--20.86M	-9.10%13.72M
Financial expense	98.13%-21.01K	98.11%-13.84K	65.06%-269.19K	-90.42%-1.81M	-52.47%-1.12M	-74.00%-732.68K	---770.53K	-2,618.65%-948.82K	---735.43K	-1,476.41%-421.08K
-Interest expense (Financial expense)	-76.08%49.42K	-66.36%46.19K	-37.42%42.96K	16,286.85%25.26K	133,928.10%206.62K	88,955.87%137.29K	--68.64K	-99.97%154.16	--154.16	-98.19%154.16
-Interest Income (Financial expense)	39.80%-1.41M	24.20%-1.21M	-30.17%-937.87K	-184.60%-3.24M	-204.39%-2.34M	-352.60%-1.59M	---720.48K	-124.87%-1.14M	---769.68K	-226.55%-352.06K
Research and development	37.48%44.7M	18.35%25.46M	89.99%13.66M	15.90%41.34M	31.53%32.52M	28.12%21.51M	--7.19M	17.00%35.67M	--24.72M	10.89%16.79M
Credit Impairment Loss	-370.20%-1.12M	-842.04%-972.36K	-516.84%-843.02K	103.42%128.81K	93.70%-237.76K	102.86%131.04K	--202.24K	-1,822.97%-3.77M	---3.77M	-71.24%-4.59M
Asset Impairment Loss	-18.76%-188.99K	33.23%-158.02K	----	-26.82%-244.84K	94.42%-159.14K	80.48%-236.67K	---571.76K	93.95%-193.06K	---2.85M	-311.46%-1.21M
Other net revenue	92.41%7.66M	6,142.01%3.11M	279.02%560.2K	2,090.01%5.24M	150.68%3.98M	99.25%-51.48K	-312.93K	93.60%-263.52K	-7.85M	-113.59%-6.86M
Invest income	181.90%3.23M	126.97%802.06K	77.71%-334.9K	-98.28%-4.58M	-137.15%-3.94M	-98.57%-2.97M	---1.5M	-24.49%-2.31M	---1.66M	-142.65%-1.5M
Asset deal income	451.86%96.07K	793.83%96.07K	365.16%50K	---25.59K	---27.3K	--10.75K	--10.75K	----	----	----
Other revenue	-32.44%5.64M	10.79%3.34M	9.03%1.69M	65.92%9.96M	1,818.69%8.35M	593.56%3.02M	--1.55M	1,545.52%6M	--435K	--435K
Operating profit	-21.19%153.92M	-17.91%115.14M	-6.13%55.45M	17.51%244.75M	18.22%195.31M	14.16%140.26M	59.08M	1.21%208.28M	-7.95%165.22M	-1.99%122.86M
Add:Non operating Income	2,755.13%6.85K	2,533.17%6.32K	--16.57K	-99.42%922.25	-99.85%240.08	-99.04%240	----	407.21%159.42K	--159.42K	25.65%25K
Less:Non operating expense	26,811.36%2.69M	26,211.40%2.63M	--2.01	-80.28%110K	-97.98%10K	-97.98%10K	----	-87.61%557.8K	--494.48K	83.30%494.48K
Total profit	-22.56%151.23M	-19.77%112.52M	-6.10%55.47M	17.68%244.64M	18.45%195.3M	14.59%140.25M	59.08M	3.26%207.88M	-7.68%164.88M	-2.17%122.39M
Less:Income tax cost	-23.62%18.77M	-25.19%13.48M	-19.37%6.39M	22.26%31.52M	15.37%24.58M	10.97%18.01M	--7.93M	3.17%25.78M	--21.31M	-1.65%16.23M
Net profit	-22.41%132.46M	-18.97%99.04M	-4.05%49.08M	17.04%213.13M	18.91%170.72M	15.14%122.23M	51.15M	3.28%182.1M	-7.58%143.58M	-2.24%106.16M
Net profit from continuing operation	-22.41%132.46M	-18.97%99.04M	-4.05%49.08M	17.04%213.13M	18.91%170.72M	15.14%122.23M	--51.15M	3.28%182.1M	--143.58M	-2.24%106.16M
Net profit of parent company owners	-22.41%132.46M	-18.97%99.04M	-4.05%49.08M	17.04%213.13M	18.91%170.72M	15.14%122.23M	--51.15M	3.28%182.1M	-7.58%143.58M	-2.24%106.16M
Earning per share
Basic earning per share	-55.24%0.9912	-53.25%0.7411	-28.04%0.4774	16.95%2.76	19.05%2.2143	14.88%1.5854	--0.6634	3.06%2.36	--1.86	-2.13%1.38
Diluted earning per share	-55.24%0.9912	-53.25%0.7411	-28.04%0.4774	16.95%2.76	19.05%2.2143	14.88%1.5854	--0.6634	3.06%2.36	--1.86	-2.13%1.38
Other composite income
Total composite income	-22.41%132.46M	-18.97%99.04M	-4.05%49.08M	17.04%213.13M	18.91%170.72M	15.14%122.23M	51.15M	3.28%182.1M	143.58M	-2.24%106.16M
Total composite income of parent company owners	-22.41%132.46M	-18.97%99.04M	-4.05%49.08M	17.04%213.13M	18.91%170.72M	--122.23M	--51.15M	--182.1M	--143.58M	----
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm